Gross Profit (Quarterly)

Gross Profit: Revenues from operations less the associated costs.

DarioHealth Corp. (DRIO) had Gross Profit of $2.96M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$5.37M
Net Income	$-18.56M
Cost of Goods Sold	$2.40M
Gross Profit	$2.96M
Operating Expenses	$14.57M
Operating Income	$-9.20M
Non-Operating Income/Expense	$-3.79M
Pre-Tax Income	$-12.99M
Normalized Pre-Tax Income	$-12.99M
Income after Taxes	$-12.99M
Income from Continuous Operations	$-12.99M
Consolidated Net Income/Loss	$-12.99M
Normalized Income after Taxes	$-12.99M
EBIT	$-9.20M
EBITDA	$-8.40M
Weighted-Average Shares Outstanding (Basic)	49.63M
Weighted-Average Shares Outstanding (Diluted)	49.63M
Earnings per Share (EPS) (Basic)	$-0.18
Earnings per Share (EPS) (Diluted)	$-0.18
Balance Sheet Financials
Current Assets	$32.17M
Property, Plant, and Equipment	$0.61M
Long-Term Assets	$76.16M
Total Assets	$108.33M
Current Liabilities	$9.75M
Long-Term Debt	$30.50M
Long-Term Liabilities	$34.59M
Total Liabilities	$44.34M
Common Equity	$63.99M
Tangible Shareholders Equity	$-10.32M
Shareholders Equity	$63.99M
Common Shares Outstanding	45.48M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-12.70M
Cash Flow from Investing Activities	$-0.07M
Cash Flow from Financial Activities	$6.94M
Beginning Cash	$27.76M
End Cash	$21.95M
Increase/Decrease in Cash	$-5.81M
Stock-Based Compensation	$4.38M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.30
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.32
Debt to Equity Ratio	0.48
Gross Margin	55.21%
Operating Margin	-171.35%
EBIT Margin	-171.35%
EBITDA Margin	--
Pre-Tax Profit Margin	-241.94%
Profit Margin	-345.73%
Free Cash Flow	$-12.78M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.05
Inventory Turnover	0.52
Receiveable Turnover	1.00
Days Sales in Receivables	90.34
Return on Equity	-20.30%
Return on Tangible Equity	125.88%
Return on Assets	-11.99%
Return on Investments	-13.75%
Book Value Per Share	$1.41
Free Cash Flow per Share	$-0.26
Operating Cash Flow per Share	$-0.26

Data from Zacks Investment Research, Inc.